These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36163034)
1. The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care. Saya S; Boyd L; Chondros P; McNamara M; King M; Milton S; Lourenco RA; Clark M; Fishman G; Marker J; Ostroff C; Allman R; Walter FM; Buchanan D; Winship I; McIntosh J; Macrae F; Jenkins M; Emery J Trials; 2022 Sep; 23(1):810. PubMed ID: 36163034 [TBL] [Abstract][Full Text] [Related]
2. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial. Walker JG; Macrae F; Winship I; Oberoi J; Saya S; Milton S; Bickerstaffe A; Dowty JG; De Abreu Lourenço R; Clark M; Galloway L; Fishman G; Walter FM; Flander L; Chondros P; Ait Ouakrim D; Pirotta M; Trevena L; Jenkins MA; Emery JD Trials; 2018 Jul; 19(1):397. PubMed ID: 30045764 [TBL] [Abstract][Full Text] [Related]
3. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program. McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680 [TBL] [Abstract][Full Text] [Related]
4. The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening. Emery JD; Jenkins MA; Saya S; Chondros P; Oberoi J; Milton S; Novy K; Habgood E; Karnchanachari N; Pirotta M; Trevena L; Bickerstaffe A; De Abreu Lourenço R; Crothers A; Ouakrim DA; Flander L; Dowty JG; Walter FM; Clark M; Doncovio S; Etemadmoghadam D; Fishman G; Macrae F; Winship I; McIntosh JG Br J Gen Pract; 2023 Aug; 73(733):e556-e565. PubMed ID: 37012077 [TBL] [Abstract][Full Text] [Related]
5. Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial. Carey M; Sanson-Fisher R; Macrae F; Hill D; D'Este C; Paul C; Doran C BMC Cancer; 2012 Feb; 12():62. PubMed ID: 22314015 [TBL] [Abstract][Full Text] [Related]
6. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program. Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080 [TBL] [Abstract][Full Text] [Related]
7. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial. Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D Trials; 2013 Jul; 14():239. PubMed ID: 23902589 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial. Chen H; Li N; Shi J; Ren J; Liu C; Zhang Y; Jiang Z; Zhang Z; Dai M BMJ Open; 2019 Apr; 9(4):e025935. PubMed ID: 31005927 [TBL] [Abstract][Full Text] [Related]
9. A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care? Saya S; McIntosh JG; Winship IM; Clendenning M; Milton S; Oberoi J; Dowty JG; Buchanan DD; Jenkins MA; Emery JD Public Health Genomics; 2020; 23(3-4):110-121. PubMed ID: 32688362 [TBL] [Abstract][Full Text] [Related]
10. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial. Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211 [TBL] [Abstract][Full Text] [Related]
11. Randomised trial to evaluate the effectiveness and impact of offering postvisit decision support and assistance in obtaining physician-recommended colorectal cancer screening: the e-assist: Colon Health study-a protocol study. Lafata JE; Shin Y; Flocke SA; Hawley ST; Jones RM; Resnicow K; Schreiber M; Shires DA; Tu SP BMJ Open; 2019 Jan; 9(1):e023986. PubMed ID: 30617102 [TBL] [Abstract][Full Text] [Related]
12. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol. Steele RJC; Digby J; Chambers JA; O'Carroll RE BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987 [TBL] [Abstract][Full Text] [Related]
13. Implications of polygenic risk for personalised colorectal cancer screening. Frampton MJ; Law P; Litchfield K; Morris EJ; Kerr D; Turnbull C; Tomlinson IP; Houlston RS Ann Oncol; 2016 Mar; 27(3):429-34. PubMed ID: 26578737 [TBL] [Abstract][Full Text] [Related]
14. Three birds with one stone: a protocol for a randomised intervention study to increase participation in cervical and colorectal cancer screening among women attending breast cancer screening. Helgestad ADL; Larsen MB; Njor S; Tranberg M; Petersen LK; Andersen B BMJ Open; 2022 Sep; 12(9):e062824. PubMed ID: 36137619 [TBL] [Abstract][Full Text] [Related]
15. An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial. Milton S; McIntosh J; Macrae F; Chondros P; Trevena L; Jenkins M; Walter FM; Taylor N; Boyd L; Saya S; Karnchanachari N; Novy K; Forbes C; Gutierrez JM; Broun K; Whitburn S; McGill S; Fishman G; Marker J; Shub M; Emery J Trials; 2021 Jul; 22(1):452. PubMed ID: 34266464 [TBL] [Abstract][Full Text] [Related]
16. Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol. Dodd N; Carey ML; Mansfield E; Oldmeadow C JMIR Res Protoc; 2017 May; 6(5):e86. PubMed ID: 28490420 [TBL] [Abstract][Full Text] [Related]
17. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study. Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
20. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients. Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]